Analysis of molecular and clinical parameters of 4-year adalimumab therapy in psoriatic patients

INTRODCUTION: Through interaction with receptors TNFR1 and TNFR2, TNF-α activates a signal path, which exacerbates an inflammatory process, constituting an inseparable element of psoriasis. AIM: To evaluate changes in the expression of TNF-α, TNFR1, TNFR2 during the 4-year-long adalimumab therapy in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Postepy Dermatol Alergol
Hlavní autoři: Wcisło-Dziadecka, Dominika, Grabarek, Beniamin, Kruszniewska-Rajs, Celina, Swinarew, Andrzej, Jasik, Krzysztof, Rozwadowska, Beata, Krawczyk, Agata
Médium: Artigo
Jazyk:Inglês
Vydáno: Termedia Publishing House 2020
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675078/
https://ncbi.nlm.nih.gov/pubmed/33240014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2020.100484
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky